ALEXANDRIA STAUB: Open Payments
NPI 1114408945 · KLAMATH FALLS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$872 in 47 payments from 9 companies in 2025. Trend: 2023 $520 · 2024 $810 · 2025 $872
Food & beverage: $773Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $265 |
| Janssen Biotech, Inc. | 6 | $167 |
| GENZYME CORPORATION | 8 | $159 |
| Lilly USA, LLC | 8 | $119 |
| UCB, Inc. | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Incyte Corporation | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| PFIZER INC. | 1 | $16 |
Products named: DUPIXENT, TREMFYA, RINVOQ, TALTZ, SKYRIZI, Bimzelx, OPZELURA, Rhapsido.
Industry payments across OR — which companies pay providers there.
